학술논문
A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck
Document Type
Article
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 February 2016 94(2):289-296
Subject
Language
ISSN
0360-3016